Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/103755
DC FieldValueLanguage
dc.contributor.authorFranco, Nuno Henrique-
dc.contributor.authorMiranda, Sonia Batista-
dc.contributor.authorKovács, Nóra-
dc.contributor.authorNagy, Attila-
dc.contributor.authorThiện, Bùi Quốc-
dc.contributor.authorReis, Flávio-
dc.contributor.authorVarga, Orsolya-
dc.date.accessioned2022-11-24T12:55:13Z-
dc.date.available2022-11-24T12:55:13Z-
dc.date.issued2021-02-16-
dc.identifier.issn2079-7737-
dc.identifier.urihttp://hdl.handle.net/10316/103755-
dc.description.abstractAlthough there is a wide range of animal models of type 2 diabetes mellitus (T2DM) used in research; we have limited evidence on their translation value. This paper provides a) a comparison of preclinical animal and clinical results on the effect of five dipeptidyl peptidase-4 (DPP4) inhibitors by comparing the pharmaceutical caused glucose changes, and b) an evaluation of methodological and reporting standards in T2DM preclinical animal studies. DPP4 inhibitors play an important role in the clinical management of T2DM: if metformin alone is not sufficient enough to control the blood sugar levels, DPP4 inhibitors are often used as second-line therapy; additionally, DPP-4 inhibitors are also used in triple therapies with metformin and sodium-glucose co-transporter-2 (SGLT-2) inhibitors or with metformin and insulin. In our analysis of 124 preclinical studies and 47 clinical trials, (1) we found no evidence of species differences in glucose change response to DPP4 inhibitors, which may suggest that, for this drug class, studies in mice and rats may be equally predictive of how well a drug will work in humans; and (2) there is good reporting of group size, sex, age, euthanasia method and self-reported compliance with animal welfare regulations in animal studies but poor reporting of justification of group size, along with a strong bias towards the use of male animals and young animals. Instead of the common non-transparent model selection, we call for a reflective and evidenced-based assessment of predictive validity of the animal models currently available.pt
dc.language.isoengpt
dc.publisherMDPI AGpt
dc.relationThis work was supported by the Portugal/Hungary Bilateral Project FCT/NKFIH- (TÉT_16-1-2016-0093) and the János Bolyai Scholarship of the Hungarian Academy of Sciences (MTA) to O.E.V., O.E.V. received a fellowship from the Hungarian Academy of Sciences (Premium Postdoctoral Research Program). FR received support from FCT, FEDER and COMPETE, via UIDP/04539/2020 (CIBB) and POCI-01-0145-FEDER-007440pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectanimal modelspt
dc.subjectpredictive validitypt
dc.subjectresearch biaspt
dc.subjecttranslational medicinept
dc.subjecttype 2 diabetes mellituspt
dc.titleAssessing Scientific Soundness and Translational Value of Animal Studies on DPP4 Inhibitors for Treating Type 2 Diabetes Mellituspt
dc.typearticlept
degois.publication.firstPage155pt
degois.publication.issue2pt
degois.publication.titleBiologypt
dc.peerreviewedyespt
dc.identifier.doi10.3390/biology10020155-
degois.publication.volume10pt
dc.date.embargo2021-02-16*
dc.identifier.pmid33669354-
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.fulltextCom Texto completo-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.languageiso639-1en-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.orcid0000-0003-3401-9554-
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
I&D CIBB - Artigos em Revistas Internacionais
I&D ICBR - Artigos em Revistas Internacionais
Show simple item record

Page view(s)

14
checked on Dec 5, 2022

Download(s)

3
checked on Dec 5, 2022

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons